Valuation ResMed, Inc.

Stocks

Market Closed - NYSE 00:00:02 05/09/2026 +04			5-day change	1st Jan Change
228.35 ^USD	-0.37%		-4.98%	-5.20%

09-03	Morgan Stanley Adjusts Price Target on ResMed to $225 From $227, Keeps Equalweight Rating	MT
09-02	ResMed Enters $450 Million Accelerated Share Repurchase Agreement With Citibank; Shares Fall 3%	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	30,691	32,133	28,117	37,762	28,145	32,940	-	-
Change	-	4.7%	-12.5%	34.31%	-25.47%	17.04%	-	-
Enterprise Value (EV) ¹	31,192	33,346	28,585	37,221	27,335	31,986	31,247	30,454
Change	-	6.9%	-14.28%	30.21%	-26.56%	17.01%	-2.31%	-2.54%
P/E	39.6x	35.9x	27.7x	27.1x	18.7x	19.6x	17.9x	16.4x
PBR	9.35x	7.76x	5.78x	6.33x	-	4.72x	4.24x	4.35x
PEG	-	2.4x	2x	0.7x	1.93x	1.7x	1.87x	1.9x
Capitalization / Revenue	8.58x	7.61x	6x	7.34x	4.98x	5.67x	5.32x	4.99x
EV / Revenue	8.72x	7.9x	6.1x	7.23x	4.84x	5.5x	5.05x	4.61x
EV / EBITDA	26.8x	25.3x	18.1x	19.8x	11.7x	14.2x	12.9x	11.8x
EV / EBIT	31.2x	27.2x	19.3x	21.1x	13.4x	15.3x	13.8x	12.5x
EV / FCF	144x	58.1x	22x	22.4x	16.6x	19.5x	17.7x	16x
FCF Yield	0.69%	1.72%	4.55%	4.46%	6.03%	5.14%	5.65%	6.25%
Dividend per Share ²	1.68	1.8	1.92	2.12	2.46	2.66	2.928	3.196
Rate of return	0.8%	0.82%	1%	0.82%	1.26%	1.16%	1.28%	1.4%
EPS ²	5.3	6.09	6.92	9.51	10.43	11.67	12.79	13.89
Distribution rate	31.7%	29.6%	27.7%	22.3%	23.6%	22.8%	22.9%	23%
Net sales ¹	3,578	4,223	4,685	5,146	5,653	5,811	6,189	6,599
EBITDA ¹	1,162	1,317	1,576	1,884	2,329	2,251	2,420	2,580
EBIT ¹	1,000	1,224	1,478	1,763	2,039	2,096	2,265	2,427
Net income ¹	779.4	897.6	1,021	1,401	1,523	1,643	1,782	1,915
Net Debt ¹	501.5	1,213	468.9	-541.2	-809.9	-954.4	-1,693	-2,486
Reference price ²	209.63	218.50	191.42	258.00	194.88	228.35	228.35	228.35
Nbr of stocks (in thousands)	146,405	147,062	146,884	146,365	144,421	144,252	-	-
Announcement Date	11/08/22	03/08/23	01/08/24	31/07/25	06/08/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
RESMED, INC.	19.57x	5.5x	14.21x	1.16%	32.94B
THERMO FISHER SCIENTIFIC, INC.	30.5x	5.4x	20.72x	0.3%	227B
DANAHER CORPORATION	35.03x	6.31x	20.02x	0.69%	146B
INTUITIVE SURGICAL, INC.	40.22x	10.44x	23.09x	-.--%	130B
BOSTON SCIENTIFIC CORPORATION	17.84x	3.65x	11.85x	-.--%	69.27B
EDWARDS LIFESCIENCES CORPORATION	35.52x	7.13x	22.55x	-.--%	51.82B
SIEMENS HEALTHINEERS AG	19.37x	2.33x	11.69x	2.63%	50.45B
AGILENT TECHNOLOGIES, INC.	29.39x	5.8x	19.69x	0.68%	42.53B
WATERS CORPORATION	71.67x	6.84x	20.83x	-.--%	40.22B
ILLUMINA, INC.	44.12x	7.18x	25.33x	-.--%	32.95B
Average	34.32x	6.06x	19.00x	0.55%	82.27B
Weighted average by Cap.	33.47x	6.30x	19.66x	0.45%